AGFAGDDAPR

Customer Review

Based on 1 Customer Validation

AGFAGDDAPR is a bioactive peptide that is a competitive and orally effective inhibitor of dipeptidyl peptidase-IV (DPP-IV). AGFAGDDAPR can enhance the level of GLP-1 in the body by inhibiting DPP-IV, thereby stimulating insulin secretion, improving β-cell function, and inhibiting abnormal proliferation of α-cells, exerting anti-diabetic effects. AGFAGDDAPR can be used for research on type 2 diabetes.

For research use only. We do not sell to patients.

  • CAS No.: 330204-04-1
  • Formula: C41H61N13O15
  • Molecular Weight:976.00
  • Storage:

    Sealed storage, away from moisture.

    Powder   -80°C, 2 years , -20°C, 1 year

    * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

  • Biological Activity
  • Chemical Information
  • Purity & Documentation
  • References
  • Help & FAQs

All Dipeptidyl Peptidase Isoforms

More
100 mg

Get Quote In-stock

Please select quantity
Amount: USD 0.00